GlassScriptPhysician profile
Imad M Mansoor
NPI 1699883082
$5,345.66
in general payments reported to CMS, 2019-2025
41 companies · $1,069 in 2025
The $1,069 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,387 · 2020: $184 · 2021: $547 · 2022: $667 · 2023: $817 · 2024: $675 · 2025: $1,069.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,560.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $979.09 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $587.01 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $537.04 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $529.78 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Amgen INC. | $502.83 | 2019-2025 | Tepezza, Repatha, Otezla |
| Lilly USA, LLC | $403.20 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Sanofi-Aventis U.S. LLC | $170.99 | 2019-2022 | |
| Exact Sciences Corporation | $148.86 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $130.56 | 2019 | |
| Dexcom, INC. | $126.60 | 2021-2025 | Dexcom G6 Transmitter |
| Corcept Therapeutics | $126.14 | 2025 | Korlym |
| Abbvie INC. | $116.95 | 2021-2023 | |
| Astellas Pharma US INC | $105.20 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.20 | 2019-2024 | Jardiance |
| Abbott Laboratories | $91.37 | 2019-2025 | Freestyle Libre 3 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Imad Mansoor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.